NEW YORK, Oct. 5, 2021 /CNW/ — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the “Company”), a leading biotech company developing psychedelic-inspired therapies, has agreed to partner with Sphere Health – a physician-founded employee benefits provider targeting treatments for people with severe mental illness – to collect and analyze multimodal data in order to improve the…

Source

Previous articlePT265 – Jessica Cadoch, MA – Cooperation, Drug Exceptionalism, and 12-step Programs
Next articleAnima Mundi: Psychedelics and The Ensouled Earth